$VHAQ News
Last published 2y ago
- 2y agoVHAQVIVEON HEALTHCARE ACQUISITION CORP. CONFIRMS COMMITMENT TO PROCEED WITH BUSINESS COMBINATION PROCESSGlobeNewswireNew York, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp (NYSE:VHAQ, VHAQR, VHAQU)) a special purpose acquisition company (the "Company") re-affirms its commitment to the previously announced business
- 2y agoVHAQVIVEON HEALTHCARE ACQUISITION CORP CONFIRMS BUSINESS COMBINATIONGlobeNewswireViveon combination with Clearday continues to move forward New York, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp (NYSE:VHAQ, VHAQW, VHAQR, VHAQU)) a special purpose acquisition company (the
- 2y agoVHAQViveon Health Acquisition Corp. Receives Commencement of Delisting Notice From the NYSEGlobeNewswireAtlanta, GA, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE:VHAQ, VHAQW, VHAQR, VHAQU the "Company")) announces that, as previously disclosed in the Current Report on Form 8-K filed on December
- 3y agoVHAQVIVEON HEALTH ACQUISITION CORP. RECEIVED AUDIT OPINION WITH GOING CONCERN EXPLANATIONGlobeNewswireATLANTA, GEORGIA, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (Viveon Health Acquisition Corp. (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU) ("Viveon" or the "Company") announced today that, as
- 3y agoCLRDVHAQViveon Healthcare Increases Consideration Offered to Clearday ShareholdersGlobeNewswireIn Amendment to the Definitive Merger Agreement Clearday Receives Higher Valuation San Antonio, Texas, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Clearday, Inc. (OTCQX:CLRD), an innovative longevity technology company using
- 3y agoVHAQViveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger AgreementGlobeNewswireNorcross GA and San Antonio, TX, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE:VHAQ) ("Viveon"), a special purpose acquisition company, and Clearday, Inc. (CLRD) ("Clearday"), an innovative
- 3y agoVHAQ(Updated) Clearday Inc. and Viveon Health Acquisition Corp. Announce Definitive Merger Agreement to Accelerate Innovative Longevity-Tech Platform to MarketGlobeNewswireCEO Jim Walesa will lead the combined company, Clearday, as Chief Executive OfficerJagi Gill, Chief Executive Officer and Chairman of Viveon Health, will join the Board of Directors of Clearday San Antonio, Texas,
- 3y agoVHAQClearday Inc. and Viveon Health Acquisition Corp. Announce Definitive Merger Agreement to Accelerate Innovative Longevity-Tech Platform to MarketGlobeNewswireCEO Jim Walesa will lead the combined company, Clearday, as Chief Executive Officer Jagi Gill, Chief Executive Officer and Chairman of Viveon Health, will join the Board of Directors of Clearday San Antonio,
- 3y agoCLRDVHAQViveon Health Acquisition Corp. and Clearday Inc. Announce Signed Letter of Intent to Merge and Create a Leading Longevity Care CompanyGlobeNewswireHealthcare and med-tech management teams join forces to accelerate longevity-tech solutions into more than 130 million American lives by 2030. Norcross, Georgia, and San Antonio, Texas, March 02, 2023 (GLOBE
- 3y agoCLRDVHAQVHAQ.UViveon Health Acquisition Corp. and Clearday Inc. Announce Signed Letter of Intent to Merge and Create a Leading Longevity Care CompanyGlobeNewswireNorcross, Georgia, and San Antonio, Texas, March 01, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE:VHAQ, VHAQW, VHAQR, VHAQU)), a special purpose acquisition company led by principals experienced in
- 3y agoVHAQVHAQ.UViveon Health Acquisition Corp. Announces Termination of Merger Agreement with Suneva Medical, Inc.GlobeNewswireNorcross, GA– , Feb. 03, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE:VHAQ, VHAQW, VHAQR, VHAQU)) (the "Company" or "Viveon"), a special purpose acquisition company, announced today that it has
- 3y agoVHAQVHAQ.UVIVEON HEALTH ACQUISITION CORP. Announces Adjournment of Special Meeting in Connection with Vote to Consummate its Initial Business Combination with Suneva Medical, Inc. Until February 3, 2023.GlobeNewswireNEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE:VHAQ, VHAQW, VHAQR, VHAQU)), a special purpose acquisition company (the "Company"), today announced that it held a special meeting of
- 3y agoVHAQVHAQ.UVIVEON HEALTH ACQUISITION CORP. Announces that Redemption Reversals in Connection with Vote to Consummate its Initial Business Combination with Suneva Medical, Inc. Are Extended Until December 23, 2022.GlobeNewswireNEW YORK, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE:VHAQ, VHAQW, VHAQR, VHAQU)), a special purpose acquisition company (the "Company"), today announced that it will allow those holders of
- 4y agoVHAQSuneva Medical Launches 30 mL PRP Gel Tubes of Amplifine, Allowing for More Variety and Efficiency in PRP TreatmentsPR NewswireSAN DIEGO, Sept. 13, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative products to change the standard of care in patient treatments, today launched the 30 mL iteration of
- 4y agoVHAQViveon Health Acquisition Corp. Announces Filing of Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Suneva MedicalBusiness WireReflects continued progress in the business combination process; transaction is expected to be completed during the second half of 2022 Viveon Health Acquisition Corp. (NYSE:VHAQ) ("Viveon Health" or "VHAQ"), a special purpose acquisition company, an
- 4y agoVHAQSuneva Medical Inc. Announces Multiple Regulatory Approvals in the U.S. and CanadaPR NewswireCanadian Regulators have approved Dermapose® All-In-One fat sizing syringe U.S. FDA 510(k) clearance for a larger volume Amplifine PRP Gel Tube SAN DIEGO, May 3, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative m
- 4y agoVHAQViveon Health Acquisition Corp. Received Audit Opinion with Going Concern ExplanationBusiness WireViveon Health Acquisition Corp. ("Viveon" or the "Company") (NYSE:VHAQ) today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2021, which was filed on March 31, 2022 with the U.S. Securities and
- 4y agoVHAQSuneva Medical Inc.'s Silhouette InstaLift Wins Best Thread Lift Treatment in NewBeauty's 2022 Beauty AwardsPR NewswireSAN DIEGO, April 13, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative medicine to change the standard of care in aesthetic treatments, announced that its Silhouette InstaL
- 4y agoVHAQViveon Health Acquisition Corp. Announces Board and Stockholder Approval to Extend Period to Consummate Business CombinationPR NewswireNORCROSS, Ga., March 21, 2022 /PRNewswire/ -- Viveon Health Acquisition Corp. (NYSE:VHAQ) ("Viveon Health" or "VHAQ"), a special purpose acquisition company, announced the approval of its board of directors (the "Board") to extend the date by which Viveo
- 4y agoVHAQSuneva Medical Appoints Michael Brower as Chief Financial OfficerPR NewswireSAN DIEGO, March 10, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative medicine to change the standard of care in aesthetic treatments, today announced that it has appoint
- 4y agoAPTSMGIRESNVHAQMoore Kuehn Encourages MGI, APTS, RESN and VHAQ Investors to Contact Law FirmGlobeNewswireNEW YORK, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair t
- 4y agoVHAQViveon Health Acquisition Corp. Announces Clarified Contribution Terms in Connection with the Extension Related to Merger Agreement with Suneva MedicalPR NewswireNORCROSS, Ga., Feb. 11, 2022 /PRNewswire/ -- Viveon Health Acquisition Corp. (NYSE:VHAQ) ("Viveon Health" or "VHAQ"), a special purpose acquisition company, today announced that it is clarifying certain terms regarding the Annual Meeting of stockholders
- 4y agoVHAQSuneva Surpasses 1 Million Syringes of Bellafill® Distributed Since the Biostimulator's InceptionPR NewswireSAN DIEGO, Feb. 8, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative medicine to change the standard of care in aesthetic treatments, today announced that it reached a miles
- 4y agoVHAQFDA Accepts Label Update for Plasma IQ™, the First FDA-Cleared Handheld Plasma Energy DevicePR NewswireSAN DIEGO, Jan. 28, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative medicine to change the standard of care in aesthetic treatments, today announced that the U.S. Food and
- 4y agoDNACVHAQZGNXBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zogenix, Inc. (Nasdaq - ZGNX), Social Capital Suvretta Holdings Corp. III (Nasdaq - DNAC), Viveon Health Acquisition Corp. (NYSE American - VHAQ)PR NewswireBALA CYNWYD, Pa., Jan. 26, 2022 /PRNewswire/ -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky or Marc Ackerman at 855-576-4847. There is no cost or fina
- 4y agoATVIDNACVHAQZGNXMoore Kuehn Encourages ATVI, ZGNX, DNAC, and VHAQ Investors to Contact Law FirmGlobeNewswireNEW YORK, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair t
- 4y agoVHAQSuneva Medical Inc. and Viveon Health Acquisition Corp. Announce Merger Agreement to Create a Leading Regenerative Aesthetics CompanyPR NewswireSAN DIEGO and NORCROSS, Ga., Jan. 12, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative medicine to change the standard of care in aesthetic treatments, and Viveon Health A
- 5y agoVHAQVHAQ.UViveon Health Acquisition Corp. Receives Noncompliance Notice Regarding Late Form 10-Q Filing From the NYSEGlobeNewswireNew York, May 28, 2021 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE: "VHAQU" or the "Company") announces that on May 25, 2021, as a result of its inability to timely file with the Securities and Exchange Commission ("SEC") its Quarterly
- 5y agoVHAQViveon Health Acquisition Corp. Announces the Separate Trading of its Common Stock, Warrants and Rights Commencing February 4, 2021GlobeNewswireNew York, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (the “Company” or “Viveon Health”) (NYSE American: VHAQU) announced that, commencing February 4, 2021, holders of the...
- 5y agoVHAQViveon Health Acquisition Corp. Announces Exercise and Closing of Over-Allotment Option in Public OfferingGlobeNewswireNEW YORK, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE: VHAQU) today announced the underwriters of its previously announced public offering of units have exercised their...
- 5y agoVHAQViveon Health Acquisition Corp. Announces Closing of $175 Million Initial Public OfferingGlobeNewswireNew York, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE: “VHAQU” or the “Company”) announced today that it closed its initial public offering of 17,500,000 units, resulting...
- 5y agoVHAQViveon Health Acquisition Corp. Announces Pricing of $175 Million Initial Public OfferingGlobeNewswireNew York, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (the “Company” or “Viveon Health”) announced today that it priced its initial public offering of 17,500,000 units at...